|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 31/506 | |
| A61K 31/4545 | |||
| G01N 33/574 | |||
| C12Q 1/68 |
| (11) | Patento numeris | 2881402 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 14184691.5 |
| Europos patento paraiškos padavimo data | 2010-02-12 | |
| (97) | Europos patento paraiškos paskelbimo data | 2015-06-10 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2017-05-10 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (30) | Numeris | Data | Šalis |
| 207484 P | 2009-02-12 | US |
| (72) |
Gu, Ting-lei, US
Tucker, Meghan, Ann, US
Haack, Herbert, US
Crosby, Katherine, Eleanor, US
Rimkunas, Victoria, McGuinness, US
|
| (73) |
Cell Signaling Technology, Inc.,
3 Trask Lane, Danvers MA 01923,
US
|
| (54) | Mutant ROS expression in human liver cancer |
| Mutant ROS expression in human liver cancer |